West Pharmaceutical Services (FRA:WPS) Net Change in Cash : €-260 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

West Pharmaceutical Services's Net Change in Cash for the three months ended in Mar. 2024 was €-232 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was €-260 Mil.

West Pharmaceutical Services Net Change in Cash Historical Data

The historical data trend for West Pharmaceutical Services's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Net Change in Cash Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

91.53

145.00

130.18

124.33

-37.05

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-7.47	-83.07	95.86	-40.99	-231.93

West Pharmaceutical Services Net Change in Cash Calculation

West Pharmaceutical Services's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	712.05	+	-338.098	+	-421.453	+	10.454
	=	-37

West Pharmaceutical Services's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 108.744 + -83.352 + -249.32 + -8.004

= -232

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services Net Change in Cash Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (FRA:WPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » Net Change in Cash

Comparable Companies

BAX RMD HOLX COO TFX ATR RGEN STVN XRAY HAE ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B TSE:4543 XSWX:STMN XPAR:DIM TSE:7733

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (FRA:WPS) Headlines